{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:19:36Z","timestamp":1790623176484,"version":"4.1.0"},"reference-count":42,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T00:00:00Z","timestamp":1392422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2014,2,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Rift Valley fever (RVF) is a veterinary and human disease in Africa and the Middle East. The causative agent, RVF virus (RVFV), can be naturally transmitted by mosquito, direct contact, or aerosol. We sought to develop a nonhuman primate (NHP) model of severe RVF in humans to better understand the pathogenesis of RVF and to use for evaluation of medical countermeasures. NHP from four different species were exposed to aerosols containing RVFV. Both cynomolgus and rhesus macaques developed mild fevers after inhalation of RVFV, but no other clinical signs were noted and no macaque succumbed to RVFV infection. In contrast, both marmosets and African green monkeys (AGM) proved susceptible to aerosolized RVF virus. Fever onset was earlier with the marmosets and had a biphasic pattern similar to what has been reported in humans. Beginning around day 8 to day 10 postexposure, clinical signs consistent with encephalitis were noted in both AGM and marmosets; animals of both species succumbed between days 9 and 11 postexposure. Marmosets were susceptible to lower doses of RVFV than AGM. Histological examination confirmed viral meningoencephalitis in both species. Hematological analyses indicated a drop in platelet counts in both AGM and marmosets suggestive of thrombosis, as well as leukocytosis that consisted mostly of granulocytes. Both AGM and marmosets would serve as useful models of aerosol infection with RVFV.<\/jats:p>","DOI":"10.1128\/jvi.02341-13","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T20:56:24Z","timestamp":1386795384000},"page":"2235-2245","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":83,"title":["Aerosolized Rift Valley Fever Virus Causes Fatal Encephalitis in African Green Monkeys and Common Marmosets"],"prefix":"10.1128","volume":"88","author":[{"given":"Amy L.","family":"Hartman","sequence":"first","affiliation":[{"name":"Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Infectious Diseases &amp; Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana S.","family":"Powell","sequence":"additional","affiliation":[{"name":"Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Bethel","sequence":"additional","affiliation":[{"name":"Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Caroline","sequence":"additional","affiliation":[{"name":"Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Schmid","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Oury","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas S.","family":"Reed","sequence":"additional","affiliation":[{"name":"Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2010.01.007"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01519-08"},{"key":"e_1_3_2_4_2","first-page":"941","article-title":"Rainfall and epizootic Rift Valley fever","volume":"63","author":"Davies FG","year":"1985","unstructured":"DaviesFGLinthicumKJJamesAD. 1985. Rainfall and epizootic Rift Valley fever. Bull. World Health Organ. 63:941\u2013943.","journal-title":"Bull. World Health Organ."},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(79)90005-1"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0290"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/378747"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.105.6.124"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0318"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2010.09-0463"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1994.50.663"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.02.017"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/v3050493"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2011.10.023"},{"key":"e_1_3_2_15_2","first-page":"347","article-title":"Rift Valley fever","volume":"27","author":"Shimshony A","year":"1983","unstructured":"ShimshonyABarzilaiR. 1983. Rift Valley fever. Adv. Vet. Sci. Comp. Med. 27:347\u2013425.","journal-title":"Adv. Vet. Sci. Comp. Med."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1991.44.278"},{"key":"e_1_3_2_17_2","first-page":"37988","article-title":"New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule","volume":"67","author":"FDA","year":"2002","unstructured":"FDA. 2002. New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final rule. Fed. Regist. 67:37988\u201337998.","journal-title":"Fed. Regist."},{"key":"e_1_3_2_18_2","volume-title":"Guidance for industry: animal models\u2014essential elements to address efficacy under the animal rule","author":"FDA","year":"2009","unstructured":"FDA. 2009, posting date. Guidance for industry: animal models\u2014essential elements to address efficacy under the animal rule. Food and Drug Administration, Washington, DC. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm078923.pdf. FDA."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300985810378650"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01311021"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01311288"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir249"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.06190-11"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300985810378597"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/382281"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1201\/9781420038118.ch5"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2011.02.014"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02501-07"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2011.05.002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1965.10480843"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.43.4.233"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02641-10"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.33.3.848-853.1981"},{"key":"e_1_3_2_34_2","first-page":"114","article-title":"Stability and infectivity of airborne Yellow fever and Rift Valley fever viruses","volume":"77","author":"Miller WS","year":"1963","unstructured":"MillerWSDemchakPRosenbergerCRDominikJWBradshawJL. 1963. Stability and infectivity of airborne Yellow fever and Rift Valley fever viruses. Am. J. Hyg. 77:114\u2013121.","journal-title":"Am. J. Hyg."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00105"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_4.S807"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/jir.1991.11.297"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/11.Supplement_4.S815"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-2516(89)80091-3"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir354"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00131-2"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/519391"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/444397"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02341-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.02341-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:44:03Z","timestamp":1646477043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.02341-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,2,15]]}},"alternative-id":["10.1128\/JVI.02341-13"],"URL":"https:\/\/doi.org\/10.1128\/jvi.02341-13","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,15]]},"assertion":[{"value":"2013-08-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-12-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-01-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}